| Literature DB >> 26712736 |
Teng-Hua Wang1,2, Jing Zhang3, Xiao-Hui Qiu4, Jun-Qi Bai5, You-Heng Gao6, Wen Xu7.
Abstract
In order to quickly and simultaneously obtain the chemical profiles and control the quality of the root of Polygonum multiflorum Thumb. and its processed form, a rapid qualitative and quantitative method, using ultra-high-performance liquid chromatography coupled with electrospray ionization-linear ion trap-Orbitrap hybrid mass spectrometry (UHPLC-LTQ-Orbitrap MS(n)) has been developed. The analysis was performed within 10 min on an AcQuity UPLC™ BEH C18 column with a gradient elution of 0.1% formic acid-acetonitrile at flow rate of 400 μL/min. According to the fragmentation mechanism and high resolution MS(n) data, a diagnostic ion searching strategy was used for rapid and tentative identification of main phenolic components and 23 compounds were simultaneously identified or tentatively characterized. The difference in chemical profiles between P. multiflorum and its processed preparation were observed by comparing the ions abundances of main constituents in the MS spectra and significant changes of eight metabolite biomarkers were detected in the P. multiflorum samples and their preparations. In addition, four of the representative phenols, namely gallic acid, trans-2,3,5,4'-tetra-hydroxystilbene-2-O-β-d-glucopyranoside, emodin and emodin-8-O-β-d-glucopyranoside were quantified by the validated UHPLC-MS/MS method. These phenols are considered to be major bioactive constituents in P. multiflorum, and are generally regarded as the index for quality assessment of this herb. The method was successfully used to quantify 10 batches of P. multiflorum and 10 batches of processed P. multiflorum. The results demonstrated that the method is simple, rapid, and suitable for the discrimination and quality control of this traditional Chinese herb.Entities:
Keywords: LTQ-Orbitrap; Polygonum multiflorum; qualitative and quantitative
Mesh:
Substances:
Year: 2015 PMID: 26712736 PMCID: PMC6272829 DOI: 10.3390/molecules21010040
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The extracted ion chromatograms (EIC) of gallic acid (GA), trans-2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucopyranoside (THSG), emodin-8-O-β-d-glucopyranoside (EMG) and emodin (EM) with three different reversed-phase columns. (A) AcQuity UPLC™ BEH C18 column (2.1 mm × 50 mm, 1.7 μm); (B) Kinetex XB C18 (2.1 mm × 100 mm, 1.7 μm) and (C) Hypersil C18 (2.1 mm × 100 mm, 5 μm). The mobile phases consisted of acetonitrile (a) and water containing 0.1% formic acid (b), with the following elution gradient program: (A) used the optimized mobile phase and gradient (see Section 3.2); (B) 13% a (0 min), 35% a (3.5 min), 90% a (7.5 min), 95% a (8.5 min) and 95% a (12 min); (C). 13% a (0 min), 35% a (12 min), 90% a (32 min), 95% a (35 min) and 95% a (40 min).
Figure 2The extracted ion chromatograms (EIC) of gallic acid (GA), trans-2,3,5,4′-tetra-hydroxystilbene-2-O-β-d-glucopyranoside (THSG), emodin-8-O-β-d-glucopyranoside (EMG) and emodin (EM) under five different chromatographic conditions: (A) methanol/water system containing 0.1% formic acid; acetonitrile/water system; (B) containing 0.1% formic acid; (C) containing 0.1% acetic acid; (D) containing 0.1% ammonium acetate and (E) containing 0.1% ammonium formate.
Effects of methanol concentration, solid-liquid ratio and extraction time on extraction yield a.
| Compound | Methanol Concentration (%) | Solid-Liquid Ratio | Extraction Time (min) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 50 | 70 | 100 | 1:50 | 1:125 | 1:250 | 15 | 30 | 60 | |
| Gallic acid | 0.46 | 0.52 | 0.67 | 0.69 | 0.88 | 0.89 | 0.26 | 0.77 | 0.73 |
| Emodin | 1.25 | 1.42 | 1.55 | 1.23 | 1.75 | 1.77 | 0.37 | 1.88 | 1.68 |
| 1.26 | 1.32 | 1.61 | 1.18 | 1.93 | 1.69 | 0.79 | 1.78 | 1.86 | |
| Emodin-8- | 0.86 | 1.46 | 1.44 | 0.43 | 1.65 | 1.44 | 0.73 | 1.42 | 1.22 |
a extraction yield (%) = the extract weight × the content of target analyte/the weight of crude drug × 100%.
Figure 3The selected reaction monitoring (SRM) chromatogram of four compounds (A) and the total ion chromatogram (TIC) of typical P. multiflorum sample (B). (1) gallic acid (GA), (2) trans-2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucopyranoside (THSG), (3) emodin-8-O-β-d-glucopyranoside (EMG) and (4) emodin (EM).
Identification of the chemical constituents in methanol extracts of CPM and PPM by UHPLC-LTQ-Orbitrap MS.
| No. | Precursor ions [M − H] | Formula | Mass Error (ppm) | MSn | Identification | |
|---|---|---|---|---|---|---|
| 1 | 0.89 | 341.1078 | C12H21O11 | 0.18 | MS2[377]: 341 (100), 215 (15) | Sucrose * |
| 377.0843 [M + Cl] | MS3: 179 (100), 161 (23), 143 (22), 113 (17) | |||||
| 2 | 1.12 | 179.0556 225.0609 [M + HCOO] | C6H11O6 | 3.38 | MS2: 161 (100), 143 (90), 119 (44), 113 (40), 89 (40) | Glucose * |
| 3 | 2.17 | 169.0136 | C7H5O5 | 2.66 | MS2: 125 (100) | gallic acid * |
| MS3: 81 | ||||||
| 4 | 4.24 | 577.1330 | C30H25O12 | −1.8 | MS2: 425 (100), 407 (48), 457 (20), 471 (17), 289 (10) | procyanidin B |
| MS3: 407 (100) | ||||||
| 5 | 4.34 | 289.0708 | C15H13O6 | 0.47 | MS2: 245 (100), 205 (42), 179 (19) | epicatechin/catechin |
| MS3: 203 (100), 227 (23), 187 (22), 161 (20) | ||||||
| 6 # | 4.48 | 531.1488 | C26H27O12 | −2.2 | MS2: 369 (100), 351 (29), 405 (21), 243 (18) | unknown |
| MS3: 351 (100) | ||||||
| 7 # | 4.63 | 549.1594 | C26H29O13 | −0.97 | MS2: 387 (100), 459 (73), 531 (22), 297 (16) | unknown |
| 8 | 4.82 | 577.1330 | C30H25O12 | −1.53 | MS2: 425 (100), 407 (48), 457 (20), 471 (17), 289 (10) | procyanidin B |
| MS3: 407 (100) | ||||||
| 9 # | 4.98 | 421.1123 | C20H21O10 | −1.38 | MS2: 259 (100) | 6-methoxyl-2-acetyl-3-methyljuglone-8- |
| MS3: 259 (100), 331 (50), 128 (20) | ||||||
| 10 | 5.02 | 613.1751 [M + HCOO] | C27H33O16 | −1.21 | MS2: 405 (100), 567 (36) | tetrahydroxystilbene- |
| MS3: 243 (100) | ||||||
| 11 | 5.37 | 405.1177 | C20H21O9 | −0.74 | MS2: 243 (100) | THSG * |
| 811.2428 [2M − H] | MS3: 225 (100), 149 (79), 137 (73), 215 (70), 173 (36) | |||||
| 12 | 5.41 | 557.1286 | C27H25O13 | −0.66 | MS2: 313 (100), 243 (30), 405 (20), 169 (5) | tetrahydroxystilbene- |
| MS3: 169 (100), 125 (20), 151 (20), 295 (17) | ||||||
| 13 | 5.71 | 557.1285 | C27H25O13 | −0.82 | MS2: 313 (100), 243 (80), 405 (70), 169 (10) | tetrahydroxystilbene- |
| MS3: 169 (100), 125 (20), 151 (20), 295 (17) | ||||||
| 14 | 5.72 | 431.0970 | C21H19O10 | −0.63 | MS2: 269 (100) | emodin-1- |
| MS3: 225 (100), 241 (21), 181 (4) | ||||||
| 15 | 5.75 | 567.1488 | C29H27O12 | −1.59 | MS2: 243 (100) | tetrahydroxystilbene- |
| MS3: 225 (100), 215 (72), 149 (67) | ||||||
| 16 | 5.90 | 551.1543 | C29H27O11 | −0.89 | MS2: 405 (100), 243 (31) | tetrahydroxystilbene-2- |
| 17 | 5.92 | 447.0919 | C21H19O11 | −0.64 | MS2: 303 (100), 285 (100) | citreorosein- |
| MS3: 285 (100), 177 (11), 125 (8) | ||||||
| 18 | 6.02 | 407.1334 | C20H23O9 | −0.64 | MS2: 245 (100) | torachrysone- |
| MS3: 230 (100) | ||||||
| 19 | 6.11 | 431.0973 | C21H19O10 | 0.11 | MS2: 269 (100) | emodin-8- |
| MS3: 225 (100), 241 (21), 197 (5) | ||||||
| 20 | 6.26 | 517.0978 | C24H21O13 | 0.26 | MS2: 473 (100), 431 (10) | emodin- |
| MS3: 269 (100), 311 (12), 225 (5) | ||||||
| 21 | 6.38 | 445.1127 | C22H21O10 | −0.22 | MS2: 283 (100), 445 (42) | physcion-8- |
| 491.1182 [M + HCOO] | MS3: 240 (100), 268 (36) | |||||
| 22 | 6.42 | 313.0345 | C16H9O7 | 0.96 | MS2: 269 | carboxyl emodin |
| MS3: 225, 241, 197 | ||||||
| 23 | 7.21 | 269.0447 | C15H9O5 | 0.33 | MS2: 225, 241 | Emodin * |
| 24 | 7.63 | 269.0446 | C15H9O5 | 0.17 | MS2: 225, 241, 254 | aloe-emodin |
| 25 | 8.30 | 283.0605 | C16H11O5 | 1.41 | MS2: 240 | physcion |
* Compared with standard compouds; # Detected only in methanol extracts of PPM.
Figure 4The proposed fragmentation pathways of peaks 12 and 13.
Figure 5Relative intensity of the extracted ion chromatograms (EIC; mean ± SD) of 12 biomarkers between PM and its processed products. The peak names were originated from Table 2. Statistics are based on three independent experiments for each sample. * p < 0.05, ** p < 0.01 and *** p < 0.001.
Calibration curves, LOD and LDQ of the investigated compounds.
| Analytes | Linear Regression Data Regression Equation | Test Range (μg/mL) | r2 | LOD a (ng/mL) | LOQ b (ng/mL) |
|---|---|---|---|---|---|
| Gallic acid | y = 3598.5x + 205.82 | 0.03–4.00 | 0.9997 | 0.03 | 0.10 |
| Emodin | y = 25639x + 2283.1 | 0.01–1.40 | 0.9916 | 0.01 | 0.02 |
| y = 652.2x − 5013.2 | 1.15–105.00 | 0.9997 | 0.01 | 0.02 | |
| Emodin-8- | y = 7690.7x + 14652 | 0.29–114.00 | 0.9998 | 0.01 | 0.06 |
a LOD refers to the limit of detection, s/n = 3; b LOQ refers to the limit of quantification, s/n = 10.
Intra- and inter-day variability for the assay of four components.
| Compound | Intra-Day ( | Inter-Day ( | ||
|---|---|---|---|---|
| Mean (μg/mL) | RSD a (%) | Mean (μg/mL) | RSD (%) | |
| Gallic acid | 0.01 | 1.27 | 0.07 | 3.27 |
| 0.25 | 1.15 | 0.25 | 1.62 | |
| 1.00 | 0.92 | 0.97 | 2.74 | |
| Emodin | 0.00 | 1.90 | 0.04 | 2.14 |
| 0.34 | 1.67 | 0.34 | 1.87 | |
| 2.56 | 1.48 | 2.50 | 2.39 | |
| 2.17 | 1.45 | 2.08 | 1.68 | |
| 10.10 | 1.23 | 10.12 | 2.71 | |
| 107.67 | 0.77 | 106.33 | 1.65 | |
| Emodin-8- | 0.37 | 1.14 | 0.37 | 2.45 |
| 1.52 | 1.49 | 1.50 | 1.49 | |
| 67.88 | 1.30 | 68.13 | 2.57 | |
a RSD (%) = (SD/mean) × 100%.
Repeatability and stability of the four analytes, expressed as RSD (%).
| Compound | Repeatability ( | Stability ( | ||
|---|---|---|---|---|
| Mean (μg/mL) | RSD a (%) | Mean (μg/mL) | RSD (%) | |
| Gallic acid | 0.33 | 3.81 | 0.34 | 2.01 |
| Emodin | 1.04 | 2.53 | 1.02 | 1.17 |
| 27.34 | 1.85 | 27.83 | 1.49 | |
| Emodin-8- | 0.83 | 2.98 | 0.80 | 1.37 |
a RSD (%) = (SD/mean) × 100%.
Recoveries of the four determined constituents.
| Compound | Amount (μg/mL) | Recovery a (%) | RSD b (%) | |
|---|---|---|---|---|
| Spiked | Found | |||
| Gallic acid | 0.26 | 0.26 ± 0.00 | 98.39 | 1.19 |
| 0.33 | 0.32 ± 0.01 | 98.87 | 1.81 | |
| 0.39 | 0.39 ± 0.00 | 98.54 | 0.04 | |
| Emodin | 0.90 | 0.91 ± 0.00 | 100.75 | 0.06 |
| 1.12 | 1.13 ± 0.02 | 100.53 | 1.43 | |
| 1.35 | 1.33 ± 0.01 | 98.73 | 1.41 | |
| 23.46 | 22.83 ± 0.14 | 97.34 | 0.63 | |
| 29.32 | 29.43 ± 0.37 | 100.37 | 1.26 | |
| 35.19 | 34.54 ± 0.40 | 98.17 | 1.18 | |
| Emodin-8- | 7.35 | 7.17 ± 0.06 | 97.56 | 0.77 |
| 9.19 | 9.16 ± 0.13 | 99.75 | 1.46 | |
| 11.03 | 11.07 ± 0.05 | 100.40 | 0.43 | |
a Recovery (%) = (detected amount − original amount)/spiked amount × 100%. b RSD (%) = (SD/mean) × 100%.
Contents of four components in 20 samples.
| No. | Content (mg/g) ( | |||
|---|---|---|---|---|
| Gallic Acid (GA) | Emodin (EM) | 2,3,5,4′-Tetrahydroxystilbene-2- | Emodin-8- | |
| A1 | 0.63 ± 0.01 | 1.01 ± 0.02 | 34.43 ± 0.59 | 21.11 ± 0.34 |
| A2 | 0.44 ± 0.05 | 0.23 ± 0.00 | 4.53 ± 0.15 | 1.32 ± 0.05 |
| A3 | 0.32 ± 0.01 | 0.18 ± 0.00 | 24.54 ± 0.93 | 7.29 ± 0.20 |
| A4 | 0.30 ± 0.04 | 0.52 ± 0.06 | 16.27 ± 0.57 | 7.98 ± 0.17 |
| A5 | 0.50 ± 0.01 | 0.82 ± 0.01 | 24.01 ± 0.76 | 14.44 ± 0.65 |
| A6 | 0.31 ± 0.00 | 2.46 ± 0.04 | 26.57 ± 0.46 | 15.77 ± 0.25 |
| A7 | 0.58 ± 0.01 | 0.32 ± 0.00 | 20.55 ± 0.67 | 3.85 ± 0.08 |
| A8 | 0.43 ± 0.01 | 0.10 ± 0.00 | 24.97 ± 0.58 | 7.83 ± 0.25 |
| A9 | 0.60 ± 0.01 | 2.38 ± 0.05 | 19.71 ± 0.23 | 15.87 ± 0.15 |
| A10 | 0.23 ± 0.00 | 3.27 ± 0.04 | 23.51 ± 0.55 | 14.59 ± 0.31 |
| B1 | 0.02 ± 0.00 | 0.49 ± 0.01 | 2.54 ± 0.04 | 2.12 ± 0.03 |
| B2 | 0.09 ± 0.00 | 0.36 ± 0.00 | 1.85 ± 0.03 | 0.35 ± 0.00 |
| B3 | 0.28 ± 0.00 | 0.45 ± 0.01 | 2.63 ± 0.04 | 3.11 ± 0.04 |
| B4 | 0.15 ± 0.01 | 0.50 ± 0.01 | 1.97 ± 0.05 | 2.59 ± 0.04 |
| B5 | 0.90 ± 0.01 | 0.85 ± 0.03 | 10.42 ± 0.37 | 2.51 ± 0.04 |
| C1 | 0.31 ± 0.01 | 0.56 ± 0.02 | 2.05 ± 0.03 | 3.49 ± 0.04 |
| C2 | 0.02 ± 0.01 | 1.13 ± 0.02 | 5.94 ± 0.10 | 3.92 ± 0.04 |
| C3 | 1.31 ± 0.04 | 0.32 ± 0.01 | 2.55 ± 0.06 | 0.47 ± 0.01 |
| C4 | 0.47 ± 0.01 | 1.31 ± 0.04 | 11.71 ± 0.41 | 4.92 ± 0.09 |
| C5 | 0.39 ± 0.01 | 0.67 ± 0.02 | 8.21 ± 0.10 | 2.62 ± 0.09 |